Citigroup’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.6K | Sell |
15,832
-3,321
| -17% | -$10.2K | ﹤0.01% | 4044 |
|
|
2025
Q1 | $37K | Sell |
19,153
-1,172
| -6% | -$2.26K | ﹤0.01% | 4192 |
|
|
2024
Q4 | $76K | Buy |
20,325
+6,831
| +51% | +$25.5K | ﹤0.01% | 4106 |
|
|
2024
Q3 | $66K | Buy |
13,494
+8,318
| +161% | +$40.7K | ﹤0.01% | 4154 |
|
|
2024
Q2 | $38.8K | Sell |
5,176
-54,490
| -91% | -$409K | ﹤0.01% | 3990 |
|
|
2024
Q1 | $1.48M | Buy |
+59,666
| New | +$1.48M | ﹤0.01% | 2067 |
|